Co-supervision PhD Lyon1-Sherbrooke-2024.pdf

The PhD project will gather the complementary expertise of the French and Canadian labs to address how the tumorigenic T cells affects IECs signaling and thus initate transformaton. At
the CRCL, the PhD student will be trained on intestinal immunology, to address the immune actors including cytokines which are responsible of the initiation of IECs transformation.
Because it is also possible that the tumorigenic cells promote IEC transformation through microbiota cross talk, he/ she will also be trained on microbiota analysis also at the CRCL. At the university of Sherbrook, he/she will analyze the effects of incriminated immunological and microbiota actors on IECs signaling responsible to transforma7on. Hence, by exploring the
novel field in oncology linking effector T lymphocytes to IEC transformtion the selected candidate will get a double expertise (Immunology/ and IECs) and should bring to the lime light unsuspected cellular and molecular mechanisms of cancer initiation which could be target to prevent from intestinal cancer apparition. The recruitment of the future PhD student is not fully finalized yet. She/he should get a strong background in cancer immunology/inflamma-on.

https://pubmed.ncbi.nlm.nih.gov/?term=marie+julien&sort=date

https://pubmed.ncbi.nlm.nih.gov/?term=rivard%20nathalie&sort=date

The PhD will be funded by both FRANCE and CANADA on the basis of 20 k€


**Application Procedure:**

The candidate should send CV letter and academic record to:

Caroline MOYRET LALLE: caroline.moyret-lalle@univ-lyon1.fr

Charlotte RIVIERE: charlotte.riviere@univ-lyon1.fr

**Application Deadline: The deadline for applications is January 30 2024**

Call for a candidate for a PhD in co-supervision between University Claude Bernard Lyon 1, FRANCE and the university of Sherbrooke, CANADA; Application Deadline: The deadline for applications is January 30 2024.

InnovInOnco.png

GRADUATE INITIATIVE “InnovInOnco”

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

GRADUATE INITIATIVE “InnovInOnco”

Files to download